chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Blood clot; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration as dose number unknown, single for COVID-19 immunization. Patient medical history and concomitant medications were not reported. On an unspecified date, patient had blood clot. Reporter stated that she did not ask them if patient had any other symptoms. She stated that she would not be providing any further information for the patient for privacy. The outcome of the event was unknown.   Information on the lot/batch number has been requested.
Partial administration of fluzone quad vaccine due to leak around needle and syringe when this provider went to administer vaccine. No apparent injury, patient denies discomfort/pain.
Following morning after receiving covid vaccine I experienced painful/stiff neck that limited neck range of motion significantly.  3 weeks later range of motion has improved however still experiencing neck pain that limits previous normal daily activities.
Mom brought child in for immunization at 12 noon on 08/22/2005 child received DTap, IPV, MMR. DTap was given right leg IM. On 08/23 in am mom noticed leg was swollen, red, warm. She called Dr. whose nurse stated that, that was a common reaction. Child went outside to play all day, In evening mom noticed that right leg injection site was bleeding along with redness, swelling and warm. Her sister was visiting and encouraged her to take child to ER. ER did blood test and started an IV right Rocephin then stated child had cellulitis. He was sent home and told to return for another dose IV Rocephin on 08/24/2005. Child also had apt with Dr. 08/24/2005. Child denies any pain in right leg and runs and plays normally. Follow up dated 09/06/2005 states, on 9/12/05 recalled mom to check on pt. Mom now states that doctor informed her the cultures were negative and the leg swelling was a local reaction.
Injection site pain in left arm after first dose; little headache; Slight fever; This is a spontaneous report from a contactable consumer (patient) reported for himself. A 82-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EM9809, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 02Mar2021 at 12:25 pm (age at vaccination was 82 years) as dose 1, single for COVID-19 immunization. The patient's medical history included diabetes diagnosed many years ago and was under control and blood sugar was very low. The patient did not have any family medical history. The patient's concomitant medications were not reported. The patient takes blood pressure and diabetes pills and was taking prior to the vaccine. No additional vaccines were administered on same date of the Pfizer Suspect. The facility where the most recent COVID-19 vaccine was administered was Hospital and not a military facility. On 02Mar2021 at 12:25 pm, the patient experienced little headache/mild headache and around 19:00-20:00 pm, the patient experienced slight fever. On an unspecified date at 13:25, the patient experienced injection site pain in left arm after first dose. The patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6203, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 23Mar2021 at 12:25 pm (age at vaccination was 82 years) as dose 2, single for COVID-19 immunization and experienced chills and fever, headache with second dose, body aches and injection site pain in left arm. With the first shot, he had no pain in his arm. No Emergency room or Physician's office visit was required. No relevant test was done. The outcome of the event injection site pain in left arm after first dose was unknown. The outcome of the other events was resolving.  No follow up attempts are possible. No further information is expected.
FEVER; CHILLS; HEADACHE AND HEAD HURTS; HARD TO DRIVE; MILD COUGH; HEAD PRESSURE; NAUSEA; DIZZINESS; FLU FEELING; SICK; AWFUL; THROW UP; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included anxiety. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805025, and batch number: 1805025 expiry: UNKNOWN) dose was not reported, administered on 08-MAR-2021 to Right Arm for prophylactic vaccination. Concomitant medications included paroxetine hydrochloride for anxiety. On MAR-2021, the subject experienced fever. On MAR-2021, the subject experienced chills. On MAR-2021, the subject experienced headache and head hurts. On MAR-2021, the subject experienced hard to drive. On MAR-2021, the subject experienced mild cough. On MAR-2021, the subject experienced head pressure. On MAR-2021, the subject experienced nausea. On MAR-2021, the subject experienced dizziness. On MAR-2021, the subject experienced flu feeling. On MAR-2021, the subject experienced sick. On MAR-2021, the subject experienced awful. On MAR-2021, the subject experienced throw up. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, chills, nausea, dizziness, flu feeling, and throw up on MAR-2021, had not recovered from headache and head hurts, mild cough, and head pressure, and the outcome of hard to drive, sick and awful was not reported. This report was non-serious.
heat; Fever; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (heat) and PYREXIA (Fever) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006021A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING HOT (heat) and PYREXIA (Fever). At the time of the report, FEELING HOT (heat) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment information were reported by the reporter
Patient received immunizations.  5 minutes afterwards developed hives on face and chest.  No trouble breathing.  15 minutes later only hives on chin.
This case was reported by a physician via sales representative and described the occurrence of injection site reaction in a subject of unspecified age and gender who was vaccinated with KINRIX, (GlaxoSmithKline).  On an unspecified date, the subject received unspecified dose of KINRIX (unknown).  At an unspecified time after vaccination with KINRIX, the subject experienced injection site reaction.  At the tie of reporting the outcome of the event was unspecified.  The sales representative was told that the physician's office had four major injection site reactions (from four different subjects) over the course of a month.  No additional information was provided.  Additional cases see A0796720A, A0796722A, and A0796723A.
This spontaneous report as received from a pharmacist refers to a male patient of unknown age. Pertinent medical history and drug reactions allergies were not reported. On 07-JAN-2013, the patient was vaccinated with a first dose of ZOSTAVAX vial 19400 plaque-forming unit (PFU) (lot number was reported as 672605/1658AA, expiration date 21-JAN-2013) subcutaneous (dose was not reported). On 22-MAY-2013, the patient was vaccinated with a second dose of ZOSTAVAX vial 19400 plaque-forming unit (PFU) (lot number H018978, expiration date 15-JAN-2014) subcutaneous (dose was not reported). Concomitant medication was not reported. No adverse effects reported. Additional information has been requested.
Body aches, chills, low grade fever and headache. Tylenol for relief with 2 day recovery.
Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Severe, Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Confusion-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Additional Details: Complained of tingling in feet and legs
pain in upper and lower gums; pain, right side of mouth/pain on roof of mouth; pain on tongue; gums were irritated; This case was reported by a consumer via call center representative and described the occurrence of gum pain in a 78-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 7th November 2021, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 8th November 2021, 1 days after receiving Shingrix, the patient experienced gum pain, oral pain, tongue pain and irritation gum. The patient was treated with antibiotics nos and mouthwash, nos (Mouthwash). On an unknown date, the outcome of the gum pain, oral pain, tongue pain and irritation gum were recovered/resolved.   It was unknown if the reporter considered the gum pain, oral pain, tongue pain and irritation gum to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient herself. The patient received 1st dose of Shingrix and the next day had pain in her upper and lower gums on the right side of her mouth, and on the roof of her mouth and tongue.  The patient reported that this lasted 2 weeks and had now resolved.  The patient reported that when this happened she visited her dentist, who did an x-ray and said that her gums were irritated.  The patient reported that her dentist prescribed her antibiotics and mouthwash.  The patient wanted more information about side effects and if she should take the 2nd dose. The patient wanted to know if this was a reported side effect. Consent obtained to contact health care professional and consumer. The reporter consented to follow up.
Client given second dose of vaccine prior to time for second dose. Dose was administered 5 days earlier than due date of 5/11/2021. Client had no adverse reactions to administration.
pt recvd vax; pain, swelling, redness of lt upper arm w/in 24 hrs of vax;
Blowing her nose; Coughing; Sick; She feels she is getting worse; Head started hurting; Really tired; Mouth became dry; Sore throat; Thirsty; She feels like crap (per MCC agent); This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (Mouth became dry), OROPHARYNGEAL PAIN (Sore throat), THIRST (Thirsty), RHINORRHOEA (Blowing her nose) and COUGH (Coughing) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: FLU.    On 05-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jul-2021, the patient experienced DRY MOUTH (Mouth became dry), OROPHARYNGEAL PAIN (Sore throat), THIRST (Thirsty), FEELING ABNORMAL (She feels like crap (per MCC agent)) and FATIGUE (Really tired). On 08-Jul-2021, the patient experienced HEADACHE (Head started hurting). On 09-Jul-2021, the patient experienced RHINORRHOEA (Blowing her nose), COUGH (Coughing), MALAISE (Sick) and CONDITION AGGRAVATED (She feels she is getting worse). At the time of the report, DRY MOUTH (Mouth became dry), OROPHARYNGEAL PAIN (Sore throat), THIRST (Thirsty), RHINORRHOEA (Blowing her nose), COUGH (Coughing), MALAISE (Sick), FEELING ABNORMAL (She feels like crap (per MCC agent)), HEADACHE (Head started hurting) and FATIGUE (Really tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient gets a flu shot and pneumonia shot earlier.  No concomitant product use was provided by the reporter.  Treatment medication included doctor told to use Chloro-septic.   Most recent FOLLOW-UP information incorporated above includes: On 30-Aug-2021: TCR document attached and reporter address updated.
Patient felt dizzy and hand tingling a few minutes after injection while sitting in waiting area of phamcy . I Gave her a bottle of water and opened exterior door for additional ventilation.  She was asked if she wanted EMS and she said yes. EMS came to pharmacy and checked her blood pressure and heart rate. EMS gave her medical advice. She declined hospital visit. After 15 minutes she stated she felt better and a friend came to pharmacy to give her a ride home
Several hours after vaccine, pt had a red "bard" around arm. The next day she had  hives all over her body. She called a 24 hr pharmacy and was told to take Benadryl. She made an appt with her Dr. in the morning and was prescribed a Medrol dose pak.
Dizziness, extreme fatigue, concussion. I lost consciousness and was unresponsive for 2 hours. I hit my head. I can't stand stand steady for longer than 10 minutes
flu-like symptoms; diarrhea; cough; runny nose; sore throat; fever; fatigue; This is a spontaneous report from a contactable consumer (patient). A 30-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; expiry date-unknown; Batch/Lot Number: not reported), via an unspecified route of administration, administered in Arm Left on 05Mar2021 08:00 as DOSE 1, SINGLE for covid-19 immunisation (age at the time of vaccination was 30 years). Medical history included polycystic ovaries(PCOS). Concomitant medications included metformin, nexium and birth control pills. No other vaccination received within 4 weeks prior to covid-19 vaccination. No covid prior to covid-19 vaccine. The patient experienced flu-like symptoms including cough, runny nose, sore throat, fever, fatigue, diarrhoea on 06Mar2021. No covid tested post vaccination. No known allergies. No treatment received. The clinical outcome of the events was recovering.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
hearing loss; Other zoster-related conditions; This spontaneous report was received from a lawyer referring to a patient (pt) of unknown age and gender. The pt's pertinent medical history, concurrent conditions and concomitant medications were not provided.     On or about 16-MAR-2017, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) for the long-term prevention of shingles and zoster-related conditions (strength, dose, route of administration, anatomical location, lot # and expiration date were not reported).  Subsequent, on an unknown date, pt was treated by a healthcare provider, including a physician, for hearing loss (deafness) and other zoster-related conditions (ill-defined disorder). As a direct and proximate result of pt's use of the zoster vaccine live (ZOSTAVAX) vaccine, pt had and would continue suffer ongoing injuries, including but not limited to mental and physician pain and suffering medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and cost included care for hospitalization, physician care, monitoring, treatment, medication and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future.   Upon internal review, deafness was considered a medically significant event.
tightness in her chest; prickling in her eyes; cough; Initial information was received on 28-Aug-2020 regarding an unsolicited valid non-serious case from a consumer/non-health care professional.  This case involves a female patient (age unspecified) who had tightness in her chest (chest discomfort), prickling in her eyes (eye pain) and cough, while she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious tightness in her chest (chest discomfort), prickling in her eyes (eye pain) and cough (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  No laboratory data was provided   It was not reported if the patient received a corrective treatment.  At the time of report, the outcome of events was recovering.  There will be no information available on lot number
Pfizer age 5y to <12 was given to patient that was not diluted. She was given 0.2 mL non diluted Pfizer vaccine.  At this time patient has had no adverse reactions.
Got kind of sick, first one was the worst one; Nightmares; This is a spontaneous report received from a contactable consumer. This male consumer (patient) reported.  A 68-year-old male patient received a dose of BNT162B2 (BNT162B2, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route, administered on 23Feb2021 as dose 1, single for COVID-19 immunization. The patient medical history includes asthma from an unspecified date and unknown ongoing and concomitant medications includes Salbutamol [ALBUTEROL].  On an unspecified date, after the vaccination, the patient experienced nightmares and Got kind of sick, first one was the worst one. The events assessed as non-serious. The outcome of the events was unknown.  No follow-up attempts possible. No further information expected.  Follow-up (23Aug2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Reports a few hours post vaccination (11/03/03) started a diffuse pruritic rash over neck, trunk and extremities. Seen at clinic on 11/4/03 Rx Benadryl 25mg QID; 11/5/03 Rx Prednisone 40mg stat. Medrol Dose Pak.
Pt was given 0.25 ml of Fluviron. Did not realize it was for ages 4 and older. No reactions. Warning was on box not on actual vial.
This spontaneous report was received from a female patient regarding herself. Patient's medical history, concurrent conditions, and concomitant medications were not reported. On 09-JAN-2019 the patient was vaccinated with PNEUMOVAX 23, intramuscular or subcutaneous injection (dose, lot number, expiry date not provided) for pneumonia shot. Since 09-JAN-2019, the patient was experiencing soreness and swelling from her shoulder down to her elbow. Patient bicep muscle also got sore and swollen. The patient visited an unspecified physician's office and received treatment for the events. The outcome of pain in extremity and peripheral swelling was reported as not recovered. Causality assessment was not provided. No product quality complaint was present.
Pain at injection site, Pain in muscles and joints, Flu like systems, nausea, Rash on trunk of body front and back.
Had flu shot 3 times in the past. With first dose 3 yrs ago within one to two hours noticed red, watery, itchy eyes and throat. Denies swelling. Was able to swallow, no cough, no wheezing, no rashes or GI symptoms. Sx lasted one day. Cleared on its owned.   The following year had a less sevever recurrence- within one hour mild itchy eyes, no discharge, no redness, and had mild itchy throat. No swelling, no rashes. Lasted one day and cleared on its own.  The third episode in Oct 2016 was milder than the previous two. She had an itchy throat, no problems with eyes, no rashes, no swelling. Sx persisted for one day.   No medical attention or medication was required with each episode.   No problems with other immunizations. Never had anything like this before. No problems with food/eggs, or insects.
This spontaneous report was received from a Nurse regarding a patient of unknown age and gender with no pertinent medical history reported. On 06-AUG-2012 the patient was vaccinated with the first dose of GARDASIL (lot number and expiration date not reported) (dose and route not specified). The patient received the second dose of GARDASIL (lot number and expiration date not reported) (dose and route not specified), on 29-JUL-2013 (reported as "today"). No adverse effect was reported. Additional information has been requested.
tested positive for Covid; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (tested positive for Covid) in a 76-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Patient had received other vaccines in the 4 weeks prior to COVID-19 vaccine.  The patient's past medical history included Pacemaker insertion (cardiac) (Patient had pacemaker which was implanted before she got the Covid-19 vaccines.). Previously administered products included for Product used for unknown indication: HEPATITIS B VACCINE on 26-Sep-2022 and INFLUENZA VACCINE on 26-Sep-2022. Past adverse reactions to the above products included No adverse event with HEPATITIS B VACCINE and INFLUENZA VACCINE.    On an unknown date, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 25-Nov-2022, the patient experienced COVID-19 (tested positive for Covid). At the time of the report, COVID-19 (tested positive for Covid) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Nov-2022, SARS-CoV-2 test: Positive.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.  On an unknown dates, patient had received 1st dose, 2nd dose, Booster dose of moderna vaccines with unknown batch/lot numbers and unknown routes.   It was reported that patient felt light headed and fatigued and lost her sense of taste and unable to eat at that time. It was reported that patient symptoms were prolonged and she went to the urgent care on 2 Dec 2022. She was on isolation for 18 days.  Treatment medication was not provided by the reporter.
Body aches and stiffens arm has rash on it and is swollen keep getting a fever headache chills
CRANKY/IRRITABLE; FELT TIRED/TIREDNESS; This spontaneous report received from a patient concerned a 38 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included rheumatoid arthritis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number was not reported) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. Non-company suspect drugs included: adalimumab (solution for injection, subcutaneous, batch number was not reported) dose and frequency were not reported from 22-MAR-2021 to 03-APR-2021 for rheumatoid arthritis. No concomitant medications were reported.  On 03-APR-2021, the subject experienced felt tired. On 05-APR-2021, the subject experienced cranky. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from cranky, and the outcome of felt tired was not reported. This report was non-serious.
Fever up to 102.5, chills, muscle and joint pain all over body, headache, tremor
Fever, Chills, Body Aches, Headache.  Took 1000mg Acetaminophen which helped reduce symptoms for about 5-6 hours. Started around 8 PM and is still continuing (through 2:30 pm 8/25/2021). it was the worst around 2am 8/25/2021 when I woke up from sleeping.